BACKGROUND: The aim of this study was to compare the risk of complications and recurrence between oncoplastic and conventional breast surgery. METHODS: This is a retrospective analysis of a consecutive series of 436 patients with stage I-III breast cancer who underwent surgery at the University Hospital of Basel between 2011 and 2018. RESULTS: The nipple/skin-sparing mastectomy (NSM/SSM) group showed significantly more delayed wound healing (32.7 vs. 5.8%, p < 0.001) and skin necrosis (13.9 vs. 1.9%, p = 0.020) compared to conventional mastectomy (CM), which corresponded to significantly higher odds of short-term complications (OR 2.34, 95% CI 1.02-5.35, p = 0.044). The incidence rate of long-term morbidity in oncoplastic breast-conserving surgery (OBCS) was significantly higher compared to conventional breast-conserving surgery (CBCS; 25.5 vs. 11.3 per 100 patient years [PY], p < 0.001), in particular concerning chronic pain (13.3 vs. 6.6, p = 0.011) and lymphedema (4.1 vs. 0.4, p = 0.003). Seroma as a long-term morbidity occurred more often in the CM group compared to the NSM/SSM group (5.8 vs. 0.5 per 100 PY, p = 0.004). Patients received adjuvant treatment earlier after CM compared to NSM/SSM (HR 1.83, 95% CI 1.05-3.19, p = 0.034). There were no significant differences in the incidence of positive margins nor in the odds of recurrence after OBCS versus CBCS and after NSM/SSM versus CM. CONCLUSIONS: Even though the present study confirmed expected differences in complications and morbidity, it suggested that oncoplastic surgery is oncologically safe. Patients undergoing NSM/SSM should be followed closely to allow early detection and treatment of frequently associated complications and ensure timely start of adjuvant therapy.
BACKGROUND: The aim of this study was to compare the risk of complications and recurrence between oncoplastic and conventional breast surgery. METHODS: This is a retrospective analysis of a consecutive series of 436 patients with stage I-III breast cancer who underwent surgery at the University Hospital of Basel between 2011 and 2018. RESULTS: The nipple/skin-sparing mastectomy (NSM/SSM) group showed significantly more delayed wound healing (32.7 vs. 5.8%, p < 0.001) and skin necrosis (13.9 vs. 1.9%, p = 0.020) compared to conventional mastectomy (CM), which corresponded to significantly higher odds of short-term complications (OR 2.34, 95% CI 1.02-5.35, p = 0.044). The incidence rate of long-term morbidity in oncoplastic breast-conserving surgery (OBCS) was significantly higher compared to conventional breast-conserving surgery (CBCS; 25.5 vs. 11.3 per 100 patient years [PY], p < 0.001), in particular concerning chronic pain (13.3 vs. 6.6, p = 0.011) and lymphedema (4.1 vs. 0.4, p = 0.003). Seroma as a long-term morbidity occurred more often in the CM group compared to the NSM/SSM group (5.8 vs. 0.5 per 100 PY, p = 0.004). Patients received adjuvant treatment earlier after CM compared to NSM/SSM (HR 1.83, 95% CI 1.05-3.19, p = 0.034). There were no significant differences in the incidence of positive margins nor in the odds of recurrence after OBCS versus CBCS and after NSM/SSM versus CM. CONCLUSIONS: Even though the present study confirmed expected differences in complications and morbidity, it suggested that oncoplastic surgery is oncologically safe. Patients undergoing NSM/SSM should be followed closely to allow early detection and treatment of frequently associated complications and ensure timely start of adjuvant therapy.
Authors: Stacey A Carter; Genevieve R Lyons; Henry M Kuerer; Roland L Bassett; Scott Oates; Alastair Thompson; Abigail S Caudle; Elizabeth A Mittendorf; Isabelle Bedrosian; Anthony Lucci; Sarah M DeSnyder; Gildy Babiera; Min Yi; Donald P Baumann; Mark W Clemens; Patrick B Garvey; Kelly K Hunt; Rosa F Hwang Journal: Ann Surg Oncol Date: 2016-07-12 Impact factor: 5.344
Authors: Amy S Colwell; Oren Tessler; Alex M Lin; Eric Liao; Jonathan Winograd; Curtis L Cetrulo; Rong Tang; Barbara L Smith; William G Austen Journal: Plast Reconstr Surg Date: 2014-03 Impact factor: 4.730
Authors: W P Weber; S D Soysal; I Fulco; M Barandun; D Babst; D Kalbermatten; D J Schaefer; D Oertli; E A Kappos; M Haug Journal: Eur J Surg Oncol Date: 2017-01-31 Impact factor: 4.424
Authors: A Chakravorty; A K Shrestha; N Sanmugalingam; F Rapisarda; N Roche; G Querci Della Rovere; F A Macneill Journal: Eur J Surg Oncol Date: 2012-03-20 Impact factor: 4.424
Authors: Cindy B Matsen; Babak Mehrara; Anne Eaton; Deborah Capko; Anastasia Berg; Michelle Stempel; Kimberly J Van Zee; Andrea Pusic; Tari A King; Hiram S Cody; Melissa Pilewskie; Peter Cordeiro; Lisa Sclafani; George Plitas; Mary L Gemignani; Joseph Disa; Mahmoud El-Tamer; Monica Morrow Journal: Ann Surg Oncol Date: 2015-07-21 Impact factor: 5.344
Authors: Min Yi; Steven J Kronowitz; Funda Meric-Bernstam; Barry W Feig; W Fraser Symmans; Anthony Lucci; Merrick I Ross; Gildy V Babiera; Henry M Kuerer; Kelly K Hunt Journal: Cancer Date: 2010-10-13 Impact factor: 6.860
Authors: Kelly A Metcalfe; Tulin D Cil; John L Semple; Lucy Dong Xuan Li; Shaghayegh Bagher; Toni Zhong; Sophia Virani; Steven Narod; Tuya Pal Journal: Ann Surg Oncol Date: 2015-07-25 Impact factor: 5.344
Authors: Colleen M McCarthy; Babak J Mehrara; Elyn Riedel; Kristen Davidge; Akili Hinson; Joseph J Disa; Peter G Cordeiro; Andrea L Pusic Journal: Plast Reconstr Surg Date: 2008-06 Impact factor: 4.730
Authors: Sami M Abujbarah; Kristen Jogerst; Heidi E Kosiorek; Sarwat Ahmad; Patricia A Cronin; William Casey; Ryan Craner; Alanna Rebecca; Barbara A Pockaj Journal: Ann Surg Oncol Date: 2022-07-18 Impact factor: 4.339